Get started
Author

Bengt Ohlsson

Observed institution: AstraZeneca (Sweden)
OpenAlex ID: A5076288682
Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein–Protein Interaction
2014 · Leifeng Cheng, Daniel Pettersen, et al. · ACS Medicinal Chemistry Letters · 39
Identification of novel GPR81 agonist lead series for target biology evaluation
2020 · Öjvind Davidsson, Kristina Nilsson, et al. · Bioorganic & Medicinal Chemistry Letters · 10
Works count: 2
Citation count: 49
H-index: 2
I10-index: 2
Year
Topic
Type